Literature DB >> 1678699

Time-specific androgen blockade with flutamide inhibits testicular descent in the rat.

D A Husmann1, M J McPhaul.   

Abstract

Inhibition of androgen action by flutamide, a nonsteroidal antiandrogen, blocked testicular descent in 40% of the testes exposed to this agent continuously from gestational day 13 through postpartal day 28. By contrast, only 11% of the testes failed to descend when blocked by 5 alpha-reductase inhibitors during the same period. Flutamide administration over narrower time intervals (gestational day 13-15, 16-17, or 18-19) revealed maximal interference with testicular descent after androgen inhibition during gestational days 16-17. No significant differences in testicular or epididymal weights were evident between descended and undescended testes; furthermore, no correlation was detected between the presence of epididymal abnormalities and testicular descent. These findings indicate that androgen inhibition during a brief period of embryonic development can block testicular descent. The mechanism through which this inhibition occurs remains to be elucidated.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1678699     DOI: 10.1210/endo-129-3-1409

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  9 in total

1.  Transcriptome analysis of the dihydrotestosterone-exposed fetal rat gubernaculum identifies common androgen and insulin-like 3 targets.

Authors:  Julia S Barthold; Yanping Wang; Alan Robbins; Jack Pike; Erin McDowell; Kamin J Johnson; Suzanne M McCahan
Journal:  Biol Reprod       Date:  2013-12-19       Impact factor: 4.285

2.  Bilateral cryptorchidism in a dog with persistent cranial testis suspensory ligaments and inverted gubernacula: report of a case with implications for understanding normal and aberrant testis descent.

Authors:  W Kersten; G J Molenaar; J M Emmen; P van der Schoot
Journal:  J Anat       Date:  1996-08       Impact factor: 2.610

3.  The effects of pre- and postnatal exposure to the nonsteroidal antiandrogen flutamide on testis descent and morphology in the Albino Swiss rat.

Authors:  N M Kassim; S W McDonald; O Reid; N K Bennett; D P Gilmore; A P Payne
Journal:  J Anat       Date:  1997-05       Impact factor: 2.610

4.  Sex differences in β-amyloid accumulation in 3xTg-AD mice: role of neonatal sex steroid hormone exposure.

Authors:  Jenna C Carroll; Emily R Rosario; Sara Kreimer; Angela Villamagna; Elisabet Gentzschein; Frank Z Stanczyk; Christian J Pike
Journal:  Brain Res       Date:  2010-10-08       Impact factor: 3.252

5.  Reduced expression of androgen receptor and myosin heavy chain mRNA in cremaster muscle of boys with nonsyndromic cryptorchidism.

Authors:  Julia Spencer Barthold; Yanping Wang; Anita Reilly; Alan Robbins; T Ernesto Figueroa; Ahmad Banihani; Jennifer Hagerty; Robert E Akins
Journal:  J Urol       Date:  2012-08-17       Impact factor: 7.450

6.  Cryptorchidism in the orl rat is associated with muscle patterning defects in the fetal gubernaculum and altered hormonal signaling.

Authors:  Julia S Barthold; Alan Robbins; Yanping Wang; Joan Pugarelli; Abigail Mateson; Ravinder Anand-Ivell; Richard Ivell; Suzanne M McCahan; Robert E Akins
Journal:  Biol Reprod       Date:  2014-06-25       Impact factor: 4.285

7.  The orl rat with inherited cryptorchidism has increased susceptibility to the testicular effects of in utero dibutyl phthalate exposure.

Authors:  Kamin J Johnson; Suzanne M McCahan; Xiaoli Si; Liam Campion; Revital Herrmann; Julia S Barthold
Journal:  Toxicol Sci       Date:  2008-07-10       Impact factor: 4.849

8.  Association of testicular undescent induced by prenatal flutamide treatment with thickening of the cremaster muscle in rats.

Authors:  Yoshiharu Matsuno; Masatoshi Komiyama; Toyofusa Tobe; Naoji Toyota; Tetsuya Adachi; Chisato Mori
Journal:  Reprod Med Biol       Date:  2003-09-26

Review 9.  Update on cryptorchidism: endocrine, environmental and therapeutic aspects.

Authors:  F Brucker-Davis; G Pointis; D Chevallier; P Fenichel
Journal:  J Endocrinol Invest       Date:  2003-06       Impact factor: 4.256

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.